Shop

Showing 145–160 of 736 results

• 

  Article: Clinical issues in the anti-angiogenic treatment of ovarian cancer

  €2.50 Add to cart
• 

  Article: Clinical issues in the management of metastatic non-small cell lung cancer (NSCLC)

  €2.50 Add to cart
• 

  Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

  €2.50 Add to cart
• 

  Article: Co-inhibition of BRAF and MEK signalling delays progression in BRAF-mutant metastatic melanoma

  €2.50 Add to cart
• 

  Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer

  €2.50 Add to cart
• 

  Article: Combined PD-1 and CTLA4 inhibition delays progression in advanced melanoma

  €2.50 Add to cart
• 

  Article: Comment on a previously published practice guidelines article

  €2.50 Add to cart
• 

  Article: Concerning a previously published Introduction

  €2.50 Add to cart
• 

  Article: Concerning a previously published practice guidelines article

  €2.50 Add to cart
• 

  Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

  €2.50 Add to cart
• 

  Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma

  €2.50 Add to cart
• 

  Article: Congress Calendar

  €2.50 Add to cart
• 

  Article: Congress Calendar

  €2.50 Add to cart
• 

  Article: Congress highlights 2018

  €2.50 Add to cart
• 

  Article: Congress highlights 2018

  €2.50 Add to cart
• 

  Article: Congress Highlights 2018 Special,

  €2.50 Add to cart